In Brief: Copley Pharmaceutical
This article was originally published in The Rose Sheet
Executive Summary
Copley Pharmaceutical: Launching its generic minoxidil 2% by mid-June, following FDA's May 23 approval of the company's ANDA, Copley says. The product will be sold as "Minoxidil Topical Solution 2% for Men Hair Regrowth Treatment" in a box depicting a balding head. Retail price is expected to be between $12 and $15 per box of two 60 ml bottles, according to the company. Copley's minoxidil approval trails those of Bausch & Lomb, Teva and Alpharm, which began shipping their private label versions of Pharmacia & Upjohn's OTC Rogaine in early May ("The Rose Sheet" May 6, p. 5)...